Program in Behavioral Neuroscience, Department of Psychology, State University of New York, University at Buffalo, United States of America.
Program in Biological Sciences, Department of Biology, State University of New York, University at Buffalo, United States of America.
Pharmacol Biochem Behav. 2023 Aug;229:173604. doi: 10.1016/j.pbb.2023.173604. Epub 2023 Jul 22.
Approximately 90 % of individuals undergoing treatment for opioid use disorder (OUD) report comorbid use of nicotine. As such, further investigation into underlying mechanisms contributing to the extreme comorbidity between nicotine and opioid use are warranted. Nicotine administration significantly escalates self-administration of opioids and this increase in motivational efficacy persists despite contingent punishment of opioid consumption. Additionally, both systemic and intra-insular administration of nicotine produces a rightward shift in the dose-response function in both morphine-induced conditioned place preference and taste avoidance paradigms, particularly at higher doses (5-20 mg/kg). Two possible interpretations arise from these outcomes. One is that nicotine may specifically affect learning about the malaise-inducing effects of morphine thus facilitating acceptance of higher doses of morphine. Another interpretation is that it more generally reduces sensitivity to the interoceptive effects of morphine such that higher doses are needed to produce comparable effects in nicotine-treated, relative to control, rats. To further address these possibilities, we asked whether nicotine administration interfered with the ability to discriminate the morphine interoceptive state, irrespective of its hedonic evaluation, at a dose that is impacted by nicotine in avoidance conditioning paradigms. First, we demonstrated that systemic nicotine pretreatment significantly attenuates taste avoidance induced by a low dose of morphine (3 mg/kg). Next, we used an occasion setting paradigm with this same dose of morphine to test whether systemic nicotine pretreatment interferes with the ability to discriminate between saline- and morphine-induced interoceptive states. Within this task, nicotine had no effect on the ability to effectively discriminate between the interoceptive effects of morphine and saline. Collectively, these data suggest that nicotine may be specifically altering the overall hedonic assessment of morphine perhaps by interfering with learning about its deleterious consequences.
大约 90%接受阿片类药物使用障碍 (OUD) 治疗的个体报告同时使用尼古丁。因此,有必要进一步研究导致尼古丁和阿片类药物使用极度共病的潜在机制。尼古丁给药显著增加了阿片类药物的自我给药,并且这种动机功效的增加持续存在,尽管阿片类药物消费受到条件惩罚。此外,系统和岛内给予尼古丁都会导致吗啡诱导的条件性位置偏好和味觉回避范式中剂量-反应函数的右移,尤其是在较高剂量(5-20mg/kg)时。这些结果产生了两种可能的解释。一种是尼古丁可能专门影响对吗啡引起不适的作用的学习,从而促进对更高剂量吗啡的接受。另一种解释是,它更普遍地降低了对吗啡内感受效应的敏感性,因此需要更高剂量的吗啡才能在尼古丁处理的大鼠中产生与对照组可比的效应。为了进一步解决这些可能性,我们询问尼古丁给药是否会干扰辨别吗啡内感受状态的能力,而不论其快感评估如何,在一个剂量下,在回避条件作用范式中,尼古丁会受到影响。首先,我们证明了系统给予尼古丁预处理显著减弱了低剂量吗啡(3mg/kg)引起的味觉回避。接下来,我们使用相同剂量的吗啡在一个场合设定范式中测试系统给予尼古丁预处理是否会干扰辨别盐水和吗啡引起的内感受状态的能力。在这个任务中,尼古丁对有效辨别吗啡和盐水的内感受效应的能力没有影响。总的来说,这些数据表明,尼古丁可能专门通过干扰对其有害后果的学习来改变吗啡的整体快感评估。